Position in BMY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$3,687,793
+$3,184,338 QoQ
Shares Held
64,002
+671.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
#635
of 2,506 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Jun 30, 2026CallValue
$57,620
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NOVEM GROUP holds $29,241,183 across 10 Drug Manufacturers - General names. BMY ranks #4 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
56,016 | $7,198,056 | |
| 2 | AMGN |
Amgen Inc
|
14,901 | $5,395,948 | |
| 3 | AZN |
Astrazeneca PLC
|
24,977 | $4,736,137 | |
| 4 | BMY |
Bristol Myers Squibb Co
This page
|
64,002 | $3,687,793 | |
| 5 | ABBV |
AbbVie Inc.
|
8,784 | $2,210,405 | |
| 6 | JNJ |
Johnson & Johnson
|
7,906 | $2,007,884 | |
| 7 | LLY |
ELI LILLY & Co
|
1,672 | $2,005,446 | |
| 8 | NVS |
Novartis AG
|
8,727 | $1,367,693 |
All Filings in BMY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,620 | 1,000 | Call | Sole | 2026-07-21 | |
| 2026-06-30 | $3,687,793 | 64,002 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $503,455 | 8,301 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $345,322 | 6,402 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $280,475 | 6,219 | Shares | Sole | 2025-11-10 | |
| 2025-03-31 | $228,284 | 3,743 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $205,086 | 3,626 | Shares | Sole | 2025-02-18 | |
| No filing history on record for this holder in this stock. | ||||||